FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Project description

A less painful alternative to knee replacement surgery

Knee replacement is an expensive, painful and complicated medical solution to osteoarthritis, the second leading cause of work disability after heart disease. FibroFix Cartilage is a product designed particularly for knee joints, comprising biostable and biocompatible material. It also allows more flexibility and aids cartilage regeneration. The FibroFix project is seeking funds to continue developing the product as a less expensive and less-painful alternative to knee surgery, hopefully obviating the need for a long post-operative recovery process resulting from conventional solutions.

Fields of science

• medical and health sciences › health sciences › public health
• medical and health sciences › clinical medicine › physiotherapy
• medical and health sciences › clinical medicine › orthopaedics
• engineering and technology › industrial biotechnology › biomaterials
• medical and health sciences › medical biotechnology › implants

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

ORTHOX LIMITED

Net EU contribution

€ 50 000,00

Address

66 Innovation Drive Milton Park
OX14 4RQ Abingdon
United Kingdom

Region

South East (England) › Berkshire, Buckinghamshire and Oxfordshire › Oxfordshire

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00